Literature DB >> 15755814

Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle.

Rosario Jimenez1, Elizabeth Belcher, Shiranee Sriskandan, Ruth Lucas, Shaun McMaster, Ivana Vojnovic, Timothy D Warner, Jane A Mitchell.   

Abstract

Bacteria stimulate macrophages as part of normal host defense. However, when this response is not limited, vascular smooth muscle may also be activated to express "vasoactive" genes (e.g., cyclooxygenase), leading to vascular collapse and septic shock. In macrophages, Toll-like receptors (TLRs) 4 and 2 transduce responses to Gram-negative and Gram-positive bacteria, respectively. However, the role of these TLRs in sensing bacteria in vascular smooth muscle is unclear. To address this question, we have cultured vascular smooth muscle cells from mice deficient in TLR4 (TLR4(-/-) mice), mice deficient in TLR2 (TLR2(-/-) mice), or control mice. Cells cultured from control or TLR2(-/-) mice, but not from TLR4(-/-) mice, expressed cyclooxygenase-2 and released increasing levels of prostaglandin E(2) after stimulation with whole Escherichia coli bacteria; the combination of IL-1beta plus TNF-alpha induced cyclooxygenase-2 in cells cultured from all three groups of animals. By contrast, Staphylococcus aureus affected cyclooxygenase-2 expression in two distinct ways. First, S. aureus induced a transient inhibition of cyclooxygenase-2 expression, which was overcome with time, and increased protein expression was noted. The effects of S. aureus on cyclooxygenase-2 expression were TLR2- and not TLR4-dependent. Thus, we show that Gram-positive and Gram-negative bacteria induce cyclooxygenase-2 in vascular smooth muscle with differing temporal profiles but with appropriate TLR2-versus-TLR4 signaling. These data have important implications for our understanding of the innate immune response in vascular cells and how it may impact vascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755814      PMCID: PMC555494          DOI: 10.1073/pnas.0407655101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells.

Authors:  M Woods; D Bishop-Bailey; J R Pepper; T W Evans; J A Mitchell; T D Warner
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

5.  Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.

Authors:  D Bishop-Bailey; S W Larkin; T D Warner; G Chen; J A Mitchell
Journal:  Br J Pharmacol       Date:  1997-05       Impact factor: 8.739

6.  Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway.

Authors:  K B Jourdan; J A Mitchell; T W Evans
Journal:  Biochem Biophys Res Commun       Date:  1997-04-28       Impact factor: 3.575

7.  Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

Authors:  R I Tapping; S Akashi; K Miyake; P J Godowski; P S Tobias
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries.

Authors:  V Stemme; J Swedenborg; H Claesson; G K Hansson
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-08       Impact factor: 7.069

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids.

Authors:  D Bishop-Bailey; J R Pepper; S W Larkin; J A Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

View more
  18 in total

Review 1.  Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis.

Authors:  B M Buchholz; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-03       Impact factor: 3.598

2.  Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.

Authors:  Hae-Sook Shin; Fengyun Xu; Aranya Bagchi; Elizabeth Herrup; Arun Prakash; Catherine Valentine; Hrishikesh Kulkarni; Kevin Wilhelmsen; Shaw Warren; Judith Hellman
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

Review 3.  Inflammation and the blood microvascular system.

Authors:  Jordan S Pober; William C Sessa
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

Review 4.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

5.  Differential effects of Gram-positive versus Gram-negative bacteria on NOSII and TNFalpha in macrophages: role of TLRs in synergy between the two.

Authors:  Mark J Paul-Clark; Shaun K McMaster; Elizabeth Belcher; Rosalinda Sorrentino; Jasmine Anandarajah; Mark Fleet; Shiranee Sriskandan; Jane A Mitchell
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

Review 6.  Is hypertension an immunologic disease?

Authors:  David G Harrison; Tomasz J Guzik; Jorg Goronzy; Cornelia Weyand
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

7.  Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function.

Authors:  R Sorrentino; P M de Souza; S Sriskandan; C Duffin; M J Paul-Clark; J A Mitchell
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

8.  Toll-like receptor 2 is essential for the sensing of oxidants during inflammation.

Authors:  Mark J Paul-Clark; Shaun K McMaster; Rosalinda Sorrentino; Shiranee Sriskandan; Lucy K Bailey; Laura Moreno; Bernhard Ryffel; Valerie F Quesniaux; Jane A Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405

9.  Sulforaphane enhances the activity of the Nrf2-ARE pathway and attenuates inflammation in OxyHb-induced rat vascular smooth muscle cells.

Authors:  X-D Zhao; Y-T Zhou; X-J Lu
Journal:  Inflamm Res       Date:  2013-06-12       Impact factor: 4.575

Review 10.  Therapeutic targeting of NOD1 receptors.

Authors:  L Moreno; T Gatheral
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.